Hb A1c – Glycated Haemoglobin
Haematology
Description
The Diabetes Control and Complications Trial (DCCT) ended after 10 years in 1993 a year earlier than planned�when the study proved that participants who kept their blood glucose levels close to normal greatly lowered their chances of having eye, kidney, and nerve disease.
Glucose in the circulation binds to haemoglobin. This combination of glucose and haemoglobin is called haemoglobin A1c or Glycated Haemoglobin (HbA1c).
The amount of HbA1c formed is directly related to the average concentration of glucose in the bloodstream.
Red blood cells have a lifespan of 2-3 months, and because of this, the amount of HbA1c measured reflects the average level of glucose during the last 2-3 months.
If a patient's diabetes is not well controlled, blood glucose levels will be high, causing higher HbA1c levels.
Indications
Diabetic patients/Population Screening
Sample Type
Whole blood ( EDTA 4.0ml Lavender )
Reference Range
19-41mmol/mol non diabetic range
42-47mmol/mol pre-diabetic range
48mmol/mol and above diabetic range
Turnaround Time
Within 1 working day
Testing Frequency
MON-FRI
External Notes
May flag up the presence of a variant haemoglobin
Please note: the above information is subject to change and we endeavour to keep this website up to date wherever necessary.
Your contact for this test
Jason Eyre BSc (Hons) Biomedical Science, FIBMS
Section Lead - Haemoglobinopathies and Red Cell Investigations
You are enquiring about
Hb A1c – Glycated Haemoglobin